You searched for lung cancer | Page 66 of 181

Median Technologies Completes FDA Q-Submission Phase for Lung Cancer Screening Software

Posted by Andy Lundin | Feb 27, 2023 | Lung Cancer |

The Q-submission phase is a regulatory step which allows regular and in-depth discussions with the FDA on key topics.

Posted by Andy Lundin | Feb 24, 2023 | Lung Cancer |

Lucence announced that Palmetto GBA finalized a foundational local coverage determination (LCD) for the LiquidHALLMARKassay.

CancerCare released an employer toolkit on biomarker testing to help employers involved in benefit design to make optimal decisions.

Posted by Andy Lundin | Feb 3, 2023 | Covid 19 |

Immunexpress detailed a study that validated the use of its SeptiCyte RAPID as a triaging tool for COVID patients requiring hospitalization.

OncoHost, a diagnostics company centered on predictive biomarker development patient care, launched its non-small lung cancer (NSCLC) test.